Recombinant multi-species UHRF1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UHRF1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of a subfamily of RING-finger type E3 ubiquitin ligases. The protein binds to specific DNA sequences, and recruits a histone deacetylase to regulate gene expression. Its expression peaks at late G1 phase and continues during G2 and M phases of the cell cycle. It plays a major role in the G1/S transition by regulating topoisomerase IIalpha and retinoblastoma gene expression, and functions in the p53-dependent DNA damage checkpoint. It is regarded as a hub protein for the integration of epigenetic information. This gene is up-regulated in various cancers, and it is therefore considered to be a therapeutic target. Multiple transcript variants encoding different isoforms have been found for this gene. A related pseudogene exists on chromosome 12. [provided by RefSeq, Feb 2014]
The Alternative Names of target: Ac2-121,E3 ubiquitin-protein ligase UHRF1,ICBP90,Inverted CCAAT box-binding protein of 90 kDa,Np95,Nuclear protein 95,Nuclear zinc finger protein Np95 (HuNp95,RING finger protein 106,RING-type E3 ubiquitin transferase UHRF1,RNF106,TDRD22,Transcription factor ICBP90,UHRF1,Ubiquitin-like PHD and RING finger domain-containing protein 1 (hUHRF1),Ubiquitin-like-containing PHD and RING finger domains protein 1,Uhrf1,hNP95,hNp95),hUHRF1,huNp95
Go
to UHRF1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP7797-Ag-1/ GM-Tg-hg-IP7797-Ag-2 | Human UHRF1 protein | Human |
| GM-Tg-rg-IP7797-Ag-1/ GM-Tg-rg-IP7797-Ag-2 | Rat UHRF1 protein | Rat |
| GM-Tg-mg-IP7797-Ag-1/ GM-Tg-mg-IP7797-Ag-2 | Mouse UHRF1 protein | Mouse |
| GM-Tg-cynog-IP7797-Ag-1/ GM-Tg-cynog-IP7797-Ag-2 | Cynomolgus/Rhesus macaque UHRF1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP7797-Ag-1/ GM-Tg-felg-IP7797-Ag-2 | Feline UHRF1 protein | Feline |
| GM-Tg-cang-IP7797-Ag-1/ GM-Tg-cang-IP7797-Ag-2 | Canine UHRF1 protein | Canine |
| GM-Tg-bovg-IP7797-Ag-1/ GM-Tg-bovg-IP7797-Ag-2 | Bovine UHRF1 protein | Bovine |
| GM-Tg-equg-IP7797-Ag-1/ GM-Tg-equg-IP7797-Ag-2 | Equine UHRF1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP7797-Ag-1/ GM-Tg-hg-IP7797-Ag-2;
GM-Tg-rg-IP7797-Ag-1/ GM-Tg-rg-IP7797-Ag-2;
GM-Tg-mg-IP7797-Ag-1/ GM-Tg-mg-IP7797-Ag-2; GM-Tg-cynog-IP7797-Ag-1/ GM-Tg-cynog-IP7797-Ag-2; GM-Tg-felg-IP7797-Ag-1/ GM-Tg-felg-IP7797-Ag-2; GM-Tg-cang-IP7797-Ag-1/ GM-Tg-cang-IP7797-Ag-2; GM-Tg-bovg-IP7797-Ag-1/ GM-Tg-bovg-IP7797-Ag-2; GM-Tg-equg-IP7797-Ag-1/ GM-Tg-equg-IP7797-Ag-2 |
| Products Name | UHRF1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | UHRF1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UHRF1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.